Home LiteratureArticle Details
PMID: 3499851 Published · ppublish English Case Reports Journal Article Research Support, Non-U.S. Gov't

Cytogenetic study of twelve human near-diploid breast cancers with chromosomal changes.

Annales de genetique ·Vol. 30 ·No. 3 ·1987-00-00 ·Pages 138-45

Gerbault-Seureau M, Vielh P, Zafrani B, Salmon R, Dutrillaux B

Abstract

The karyotypes of 12 fresh breast cancers, including two of the male, selected for their near-diploidy and their slight number of anomalies, i.e. less than 10 rearranged chromosomes, are reported. A clonal evolution could be demonstrated in 4 cases. Most of chromosomal imbalances result from structural rearrangement, frequently after breakage in juxtacentromeric heterochromatin. There does not seem to exist a specific breakpoint, but many of the imbalances are recurrent. They are, by decreasing order of frequency: gain of 1q, (7 cases), losses of 11q, 16q and 1p (5 cases), losses of 8p and 13q (4 cases), gain of 8q and losses of 6q and 17p (3 cases). None of these anomalies can be regarded as primary, but they are likely to be selected because they confer a slight selective advantage for the carrier cells during the tumoral progression.

MeSH Terms
Breast Neoplasms/genetics Chromosome Aberrations Chromosome Disorders Diploidy Female Humans Karyotyping Male
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Gerbault-Seureau M
UA 620 CNRS, Section de Biologie, Institut Curie, Paris, France.
Vielh P
Zafrani B
Salmon R
Dutrillaux B
Article Info
Journal
Annales de genetique
Abbr.
Ann Genet
ISSN
0003-3995
Published
1987-00-00
Pages
138-45
Language
English
Region
Netherlands
NLM ID
0370562
Subset
IM
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]